Thursday, August 1, 2019

Zydus completes phase III trials of Diabetes drug in India: Company

Zydus completes phase III trials of Diabetes drug in India: Company "The trial was a multi-centric, randomised, double blind study to evaluate the safety and efficacy of 2mg and 4mg of Saroglitazar compared to Pioglitazone 45mg in patients with type 2 Diabetes Mellitus.

from Moneycontrol Business News https://ift.tt/2Kxa80H
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

FIIs ease bearish bets post-Budget, but charts warn of range-bound Nifty: Anand James

Foreign investors are reducing their negative bets on the market after the Budget. However, the market's overall sentiment remains delic...